Aspira Women's Health Inc.
AWHL
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 2.35M | 2.26M | 2.42M | 2.15M | 2.13M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.35M | 2.26M | 2.42M | 2.15M | 2.13M |
| Cost of Revenue | 860.00K | 902.00K | 1.00M | 939.00K | 911.00K |
| Gross Profit | 1.49M | 1.36M | 1.42M | 1.21M | 1.22M |
| SG&A Expenses | 4.43M | 4.20M | 4.88M | 5.04M | 4.30M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.78M | 6.00M | 6.82M | 6.86M | 6.27M |
| Operating Income | -3.43M | -3.74M | -4.39M | -4.71M | -4.14M |
| Income Before Tax | -1.39M | -3.55M | -3.53M | -4.63M | -3.09M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.39M | -3.55M | -3.53M | -4.63M | -3.09M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.39M | -3.55M | -3.53M | -4.63M | -3.09M |
| EBIT | -3.43M | -3.74M | -4.39M | -4.71M | -4.14M |
| EBITDA | -3.42M | -3.72M | -4.37M | -4.68M | -4.10M |
| EPS Basic | -0.08 | -0.23 | -0.28 | -0.39 | -0.30 |
| Normalized Basic EPS | -0.13 | -0.14 | -0.18 | -0.24 | -0.22 |
| EPS Diluted | -0.08 | -0.23 | -0.28 | -0.39 | -0.30 |
| Normalized Diluted EPS | -0.13 | -0.14 | -0.18 | -0.24 | -0.22 |
| Average Basic Shares Outstanding | 16.72M | 15.41M | 12.52M | 11.85M | 10.41M |
| Average Diluted Shares Outstanding | 16.72M | 15.41M | 12.52M | 11.85M | 10.41M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |